Jesse S Boehm

22PUBLICATIONS
76CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 09, 2024
Precision preclinical modeling to advance cancer treatment.

David H Gutmann, Jesse S Boehm, Elinor K Karlsson

|Jun 07, 2024
Germline variation contributes to false negatives in CRISPR-based experiments with varying burden across ancestries.

Sean A Misek, Aaron Fultineer, Jeremie Kalfon

|Apr 04, 2024
Radical Collaboration: Reimagining Cancer Team Science.

Jesse S Boehm, Tyler Jacks

|Oct 18, 2022
Author Correction: Massively parallel phenotyping of coding variants in cancer with Perturb-seq.

Oana Ursu, James T Neal, Emily Shea

|Apr 19, 2022
Phosphate dysregulation via the XPR1-KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer.

Daniel P Bondeson, Brenton R Paolella, Adhana Asfaw

|Jan 21, 2022
Massively parallel phenotyping of coding variants in cancer with Perturb-seq.

Oana Ursu, James T Neal, Emily Shea

Pageof 4

Frequent Collaborators

9 joint publications

William C Hahn

8 joint publications

Aviad Tsherniak

7 joint publications

Todd R Golub

6 joint publications

Francisca Vazquez